Showing results (771-780 of 5,687) with videos related to
Sort By:
Pageof 569
The Oncologist|October 30, 2025
Examining inpatient chemotherapy utilization among patients with cancer and impact on outcomesGiulia Petrone, Shivani Handa, Justine Anderson, et al.The Oncologist|December 3, 2025
A phase II study of trifluridine/tipiracil in combination with ramucirumab in advanced, refractory gastric, or gastroesophageal junction adenocarcinomasDae Won Kim, Richard D Kim, Maria Martinez Jimenez, et al.The Oncologist|September 24, 2025
Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancerJonathan D Sorah, Dominic T Moore, Matthew J Reilley, et al.The Oncologist|September 19, 2025
PARP inhibitors in gastric cancer: unlocking precision oncologyDerek Tai, Vitor Goes, Sharanya Kumar, et al.The Oncologist|September 19, 2025
Bridging adjuvant treatment gaps: low and intermediate risk endometrial carcinoma patients care in Salah Azaiez Institute in TunisiaEmna Boudhina, Semia Zarraa, Ghada Sahraoui, et al.The Oncologist|August 12, 2025
Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-Designated Comprehensive Cancer CentersAndrew Hantel, Eric C Blackstone, Anna C Revette, et al.The Oncologist|September 19, 2025
Large language model processing capabilities of ChatGPT 4.0 to generate molecular tumor board recommendations-a critical evaluation on real world dataMaximilian Schmutz, Sebastian Sommer, Julia Sander, et al.The Oncologist|August 19, 2025
Acquired Hemophilia due to Immune Checkpoint Inhibitors: A Case Series Introducing Emicizumab TreatmentLouis Wolff, Carolin Ertl, Lucie Heinzerling, et al.The Oncologist|October 16, 2025
Trophoblast cell-surface antigen 2 expression in digestive neoplasms: a promising target for antibody-drug conjugatesJinru Yang, Fangyuan Zhang, Xing Cai, et al.Pageof 569